tru Independence’s ICU Medical ICUI Stock Holding History

tru Independence’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9	Closed	-$2	–	578
2020 Q2	$2	Hold	9	–	–	﹤0.01%	799
2020 Q1	$2	Hold	9	–	–	﹤0.01%	629
2019 Q4	$2K	Buy	+9	New	+$1.55K	﹤0.01%	802

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

tru Independence's ICUI Position: Q3 2020 in Review

tru Independence sold out of ICU Medical (ICUI) in Q3 2020, closing a stake of 9 shares — an estimated $2 sold.

tru Independence first reported a position in ICUI in Q4 2019 and held it in 3 quarters. The position peaked at $2K in Q4 2019. 283 funds tracked by Wall St. Rank hold ICUI as of Q3 2020.

tru Independence reported no remaining ICU Medical position as of Q3 2020 after selling out during the quarter.
tru Independence sold 9 ICU Medical shares in Q3 2020, an estimated $2.
tru Independence first reported a position in ICU Medical in Q4 2019 and held it in 3 quarters.
tru Independence's ICU Medical position peaked at $2K in Q4 2019.
283 funds tracked by Wall St. Rank held ICU Medical as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.